MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as C$0.06 and last traded at C$0.07, with a volume of 93395 shares changing hands. The stock had previously closed at C$0.06.
MediPharm Labs Stock Performance
The company has a quick ratio of 3.10, a current ratio of 3.11 and a debt-to-equity ratio of 5.90. The company has a market cap of C$26.72 million, a price-to-earnings ratio of -1.63 and a beta of 0.88. The stock has a 50 day simple moving average of C$0.07 and a 200 day simple moving average of C$0.07.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Featured Articles
- Five stocks we like better than MediPharm Labs
- Do ETFs Pay Dividends? What You Need to Know
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- There Are Different Types of Stock To Invest In
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- How to Use the MarketBeat Stock Screener
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
